Role of alpha-2 adrenergic receptors on anesthesia and pain transmission

α2肾上腺素受体对麻醉和疼痛传递的作用

基本信息

  • 批准号:
    08457405
  • 负责人:
  • 金额:
    $ 4.8万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1998
  • 项目状态:
    已结题

项目摘要

For the last decade, alpha-2 adrenergic agonists such as clonidine have been extensively used for clinical anesthesia to provide better patients' care in perioperative periods. When given clonidine preoperatively as a premedicant for patients undergoing anesthesia and surgery it Would reduce requirements of inhalational and intravenous anesthetic agents, and opioids, provide stable hemodynamics, and enhance the action of vasopressors such as phenylephrine. When clonidine given intrathecally, it would produce a potent spinal antinociception and prolonged spinal anesthesia with local anesthetics. To elucidate some of mechanism(s) and roles for clinical efficacy of alpha-2 adrenoceptor agonists, we have done several studies, Using the cranial window technique, we found that clonidine produces cerebral vasoconstriction via activation of alpha-2 adrenoceptors of the pial vessels in a dose-related manner. When alpha-2 adrenoceptor agonists, clonidine, dexmedetomidine and tizanidine, were given into the epidural space or intravenously in rats, they produced almost 5 times greater antinociception with epidural administration as compared with those with their intravenous administration. The rank of order for their spinal antinociceptive action was identical with those of alpha-2 adrenergic receptor binding affinity of spinal' cord and brain. Brain alpha-2-adrenoceptors are up-regulated in morphine dependent guinea pigs and clonidine could reduced opiate withdrawal sings in morphine-dependent animals. We also found that patients given clonidine as premedicant showed a significantly augmented responses to ephedrine in propofol anesthesia to reduce epinephrine test dose for epidural anesthesia. Also we found that clonidine premedication modifies responses to alpha1- and beta-_2 adrenoceptor agonists and baroreflex sensitivity.
在过去的十年里,α-2肾上腺素能激动剂如可乐定被广泛用于临床麻醉,以便在围手术期为患者提供更好的护理。当可乐定作为麻醉和手术患者的术前药物时,它将减少吸入和静脉麻醉剂以及阿片类药物的需求,提供稳定的血流动力学,并增强苯肾上腺素等血管升压剂的作用。鞘内注射可乐定可产生强烈的脊椎抗伤害性作用,延长局部麻醉剂的脊麻时间。为了阐明α-2肾上腺素能受体激动剂的某些作用机制(S)及其在临床疗效中的作用,我们已经进行了多项研究,利用颅窗技术,我们发现可乐定通过激活软脑膜血管的α-2肾上腺素能受体而产生脑血管收缩作用,并呈剂量相关。α-2肾上腺素能受体激动剂可乐定、右美托咪定和替扎尼定在大鼠硬膜外腔或静脉给药时,硬膜外给药的抗伤害性作用是静脉给药的近5倍。其脊髓抗伤害性作用的顺序与脊髓和脑的α2肾上腺素能受体结合亲和力的顺序一致。在吗啡依赖的豚鼠中,脑α-2肾上腺素受体上调,可乐定可以减少吗啡依赖动物的阿片戒断反应。我们还发现,在异丙酚麻醉中,给予可乐定作为预给药的患者对麻黄碱的反应显著增强,以减少硬膜外麻醉的肾上腺素试验剂量。我们还发现,可乐定预先用药可以改变对α1和β2肾上腺素能受体激动剂的反应和压力感受器的敏感性。

项目成果

期刊论文数量(38)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
太田,丹羽,野崎,浅野,竹田,土肥: "モルヒネ依存モルモットにおける脳内α_2-アドレナリン受容体の変動" 麻酔. 46. 640-643 (1998)
Ota、Niwa、Nozaki、Asano、Takeda、Doi:“吗啡依赖性豚鼠大脑 α_2 肾上腺素受体的变化” 麻醉 46. 640-643 (1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Watanabe Y,Iida H,Tanaabe K,Ohata H,Dohi S: "Clonidine premedication modifies responses to adrenoceptor agonists and baroreflex sensitivity." Can J Anaesth. 45. 1084-1090 (1998)
Watanabe Y、Iida H、Tanaabe K、Ohata H、Dohi S:“可乐定术前用药可改变对肾上腺素受体激动剂的反应和压力反射敏感性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Watanabe Y,Iida H,Tanabe K,Ohata H,Dohi S: "Clonidine premedication modifies responses to adrenoceptor agonists and baroreflex sensitivity" Canadian Joural of Anaesthesia. 45. 1084-1090 (1998)
Watanabe Y、Iida H、Tanabe K、Ohata H、Dohi S:“可乐定术前用药可改变对肾上腺素受体激动剂的反应和压力反射敏感性”《加拿大麻醉杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ohata S,Miwa M,Nozaki M,Asano T,Dohi S: "Changes of alpha 2-adrenoceptor binding nature in guinea-pigs following the development of morpphine dependence." Masui. 46. 640-643 (1997)
Ohata S、Miwa M、Nozaki M、Asano T、Dohi S:“吗啡依赖性发展后豚鼠 α 2-肾上腺素受体结合性质的变化。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Zeng WA,Dohi S,Shimonaka H,Asano T,Kasuya Y: "Na^+ pump inhibitor potentiates spinal antinociception with clonidinne in rats." New Balanced Anesthesia, Edt by K.Mori et al.317-319 (1998)
Zeng WA、Dohi S、Shimonaka H、Asano T、Kasuya Y:“Na^泵抑制剂可增强大鼠中可乐定的脊髓镇痛作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DOHI Shuji其他文献

DOHI Shuji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DOHI Shuji', 18)}}的其他基金

A role of Na^+-K^+ATPase (Na^+pump) on signaling proteins of action anesthetic and its structural change
Na^-K^ATP酶(Na^泵)对作用麻醉信号蛋白的作用及其结构变化
  • 批准号:
    19209050
  • 财政年份:
    2007
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Anesthesia and Pain Signal transmission and Control Mechanisms of Ion transporters
麻醉与疼痛离子转运蛋白的信号传递与控制机制
  • 批准号:
    14207059
  • 财政年份:
    2002
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
A slow-release opioids drug system for postoperative pain relief
用于缓解术后疼痛的缓释阿片类药物系统
  • 批准号:
    12557129
  • 财政年份:
    2000
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Anesthesia and Pain Signal transmission and Role of Ion transporters at Spinal Cord
麻醉和疼痛信号传输和离子转运蛋白在脊髓中的作用
  • 批准号:
    11307027
  • 财政年份:
    1999
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Cardiopulmonary Reflex Responses during Nitric Oxide inhalation
吸入一氧化氮时的心肺反射反应
  • 批准号:
    06454442
  • 财政年份:
    1994
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Mechanisms of Anesthesia-related drugs on Cerebral Microcirculation - A In Vivo Study Using Intravital Microscope
麻醉相关药物对脑微循环的影响机制——活体显微镜体内研究
  • 批准号:
    02454350
  • 财政年份:
    1990
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

POISE-2: A large, international, placebo-controlled, factorial trial to assess the impact of clonidine and aspirin in patients undergoing noncardiac surgery who are at risk of a perioperative cardiovascular event
POISE-2:一项大型国际安慰剂对照析因试验,旨在评估可乐定和阿司匹林对接受非心脏手术且有围手术期心血管事件风险的患者的影响
  • 批准号:
    nhmrc : 1004149
  • 财政年份:
    2011
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Project Grants
Efficacy of clonidine in reducing iatrogenic-induced opioid dependence in infants
可乐定减少婴儿医源性阿片类药物依赖的功效
  • 批准号:
    8066685
  • 财政年份:
    2010
  • 资助金额:
    $ 4.8万
  • 项目类别:
Efficacy of clonidine in reducing iatrogenic-induced opioid dependence in infants
可乐定减少婴儿医源性阿片类药物依赖的功效
  • 批准号:
    8272767
  • 财政年份:
    2010
  • 资助金额:
    $ 4.8万
  • 项目类别:
Efficacy of clonidine in reducing iatrogenic-induced opioid dependence in infants
可乐定减少婴儿医源性阿片类药物依赖的功效
  • 批准号:
    7875132
  • 财政年份:
    2010
  • 资助金额:
    $ 4.8万
  • 项目类别:
DYNAMIC MECHANISMS OF PAIN MODULATION-SYSTEMIC CLONIDINE
疼痛调节的动态机制——系统性可乐定
  • 批准号:
    7951386
  • 财政年份:
    2009
  • 资助金额:
    $ 4.8万
  • 项目类别:
CLONIDINE TO PREVENT IMPLANTABLE CARDIOVERTER DEFIBRILLATOR FIRING
可乐定可防止植入式心脏复律除颤器起火
  • 批准号:
    7604906
  • 财政年份:
    2007
  • 资助金额:
    $ 4.8万
  • 项目类别:
DYNAMIC MECHANISMS OF PAIN MODULATION-SYSTEMIC CLONIDINE
疼痛调节的动态机制——系统性可乐定
  • 批准号:
    7607714
  • 财政年份:
    2007
  • 资助金额:
    $ 4.8万
  • 项目类别:
CLONIDINE-INDUCED SPRINAL ACETYLCHOLINE RESEARCH
可乐定诱导的螺旋乙酰胆碱研究
  • 批准号:
    7607684
  • 财政年份:
    2007
  • 资助金额:
    $ 4.8万
  • 项目类别:
CLONIDINE-INDUCED SPRINAL ACETYLCHOLINE RESEARCH
可乐定诱导的螺旋乙酰胆碱研究
  • 批准号:
    7376694
  • 财政年份:
    2006
  • 资助金额:
    $ 4.8万
  • 项目类别:
Mechanism of ethanol-clonidine synergistic sedation
乙醇-可乐定协同镇静作用机制
  • 批准号:
    6886526
  • 财政年份:
    2005
  • 资助金额:
    $ 4.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了